Assessing Clinical Outcomes in Alzheimer's Disease Agitation
Study sponsor: Axsome Therapeutics, Inc. · AXSM
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-11-21Actual
Enrollment · participants178Actual
Source updated2023-11-29Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.